NEA 12 GP, LLC's Net Worth
$1.16 Billion
Who is NEA 12 GP, LLC?
NEA 12 GP, LLC has an estimated net worth of $1.16 Billion. This is based on reported shares across multiple companies, which include OPOWER, INC., Workday, Inc., Echo Global Logistics, Inc., FUSION-IO, INC., TriVascular Technologies, Inc., HYPERION THERAPEUTICS INC, CHANNELADVISOR CORP, Groupon, Inc., Zosano Pharma Corp, Tintri, Inc., TREVENA INC, PROTEOSTASIS THERAPEUTICS, INC., ARDELYX, INC., SUNESIS PHARMACEUTICALS INC, Liquidia Technologies Inc, PEPLIN INC, ARYx Therapeutics, Inc., and HEMOSENSE INC.
SEC CIK
NEA 12 GP, LLC's CIK is 0001383389
Past Insider Trading and Trends
2012 was NEA 12 GP, LLC's most active year for acquiring shares with 25 total transactions. NEA 12 GP, LLC's most active month to acquire stocks was the month of January. 2014 was NEA 12 GP, LLC's most active year for disposing of shares, totalling 35 transactions. NEA 12 GP, LLC's most active month to dispose stocks was the month of January. 2015 saw NEA 12 GP, LLC paying a total of $23,518,351.15 for 2,794,565 shares, this is the most they've acquired in one year. In 2015 NEA 12 GP, LLC cashed out on 2,384,221 shares for a total of $109,674,166.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SUNESIS PHARMACEUTICALS INC (VIRX) Snapshot price: $0.5601
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.41% | -266.70K |
$7.97 | -$2,126,726.84 | 4.66M |
Aug 27 - Aug 29
| |||
Form 4
| -12.61% | -710.54K |
$6.63 | -$4,708,757.48 | 4.93M |
Aug 8 - Aug 12
| |||
Form 4
|
∞
| 33.82M |
$0.28 |
—
| 33.82M |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PEPLIN INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.30M |
$16.99 | -$22,117,268.53 |
0
|
Nov 11
| |||
Form 4
| +1.18% | 15.22K |
$0.49 | $7,457.09 | 1.3M |
Mar 10 - Mar 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ARYx Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.47M |
$0.07 | -$326,257.00 |
0
|
Mar 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
HEMOSENSE INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
OPOWER, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -8.99M |
$10.30 | -$92,594,589.80 |
0
|
Jun 14
| |||
Form 4
|
∞
| 8.99M |
—
|
—
| 8.99M |
Apr 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |